Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments – Market Insights – Asia Pacific

The Asia Pacific open surgery instrument market was negatively impacted by the COVID-19 pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. However, the market has been recovering strongly and will exhibit moderate growth over the forecast period, fueled mainly by an expanding patient pool, attributable to an aging population and rising disease prevalence, and thus rising procedure volumes. In China and India, market growth will be supported by improving healthcare infrastructure, while the open surgery markets in Australia and South Korea will be primarily driven mainly by the continued uptake of innovative premium-priced products. However, rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion in Australia during the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for open surgery instruments in the Asia Pacific region from 2019 through 2031.

The Asia Pacific open surgery instrument market will grow moderately during the forecast period.

What factors are driving and limiting the open surgery instrument market in Asia Pacific countries?

Which open surgery instrument market segment will see the strongest growth in the region during the forecast period?

The COVID-19 pandemic has negatively affected the open surgery instrument market in the Asia Pacific region.

How has the COVID-19 pandemic impacted the open surgery instruments market in the Asia Pacific region?

How has the impact of COVID-19 varied among the different procedures and device segments in the open surgery instrument market?

What has been the extent of recovery in 2021, and when is full recovery expected?

Healthcare professionals are increasingly adopting advanced direct energy devices for open surgical procedures.

What factors are driving growth of direct energy device segment in the Asia Pacific market?

How will ASPs change during the forecast period as a result of this trend?

How are competitors in this segment performing, and what strategies are they pursuing for revenue expansion?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…